Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Concentrix (CNXC) Shares Issued (2021 - 2025)

Concentrix's Shares Issued history spans 5 years, with the latest figure at -$13000.0 for Q4 2025.

  • For Q4 2025, Shares Issued rose 97.47% year-over-year to -$13000.0; the TTM value through Nov 2025 reached $4.0 million, down 20.91%, while the annual FY2025 figure was $4.0 million, 20.91% down from the prior year.
  • Shares Issued for Q4 2025 was -$13000.0 at Concentrix, down from $2.4 million in the prior quarter.
  • Across five years, Shares Issued topped out at $6.8 million in Q4 2021 and bottomed at -$513000.0 in Q4 2024.
  • The 5-year median for Shares Issued is $2.0 million (2023), against an average of $2.0 million.
  • The largest annual shift saw Shares Issued crashed 126.2% in 2024 before it skyrocketed 97.47% in 2025.
  • A 5-year view of Shares Issued shows it stood at $6.8 million in 2021, then tumbled by 60.35% to $2.7 million in 2022, then decreased by 27.67% to $2.0 million in 2023, then tumbled by 126.2% to -$513000.0 in 2024, then surged by 97.47% to -$13000.0 in 2025.
  • Per Business Quant, the three most recent readings for CNXC's Shares Issued are -$13000.0 (Q4 2025), $2.4 million (Q3 2025), and -$1000.0 (Q2 2025).